BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20593577)

  • 21. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
    Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
    Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease with dementia, lewy-body disorders and alpha-synuclein: recent advances and a case report.
    Wu CK
    Acta Neurol Taiwan; 2011 Mar; 20(1):4-14. PubMed ID: 21560084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain volumetry in Parkinson's disease with and without dementia: where are the differences?
    Lee SH; Kim SS; Tae WS; Lee SY; Lee KU; Jhoo J
    Acta Radiol; 2013 Jun; 54(5):581-6. PubMed ID: 23474765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dementia with Lewy bodies and Parkinson's disease dementia may best be viewed as two distinct entities.
    Revuelta GJ; Lippa CF
    Int Psychogeriatr; 2009 Apr; 21(2):213-6. PubMed ID: 19173761
    [No Abstract]   [Full Text] [Related]  

  • 25. [Parkinson's disease dementia: correlations between clinical, neuropsychological and neuropathological features].
    Kiesmann M; Vogel T; Kaltenbach G; Mohr M
    Rev Neurol (Paris); 2010; 166(6-7):653-6. PubMed ID: 20219224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease: epidemiology, (differential) diagnosis, therapy, relation to dementia.
    Oertel WH
    Arzneimittelforschung; 1995 Mar; 45(3A):386-9. PubMed ID: 7763330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-synuclein imaging: a critical need for Parkinson's disease research.
    Eberling JL; Dave KD; Frasier MA
    J Parkinsons Dis; 2013; 3(4):565-7. PubMed ID: 24192754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease dementia--an overlooked major illness.
    Libow LS
    Geriatrics; 2007 May; 62(5):11-2. PubMed ID: 17489642
    [No Abstract]   [Full Text] [Related]  

  • 29. [Parkinson's disease accompanied by dementia--a case of concurrent Parkinson's and Alzheimer's diseases (author's transl)].
    Sugimura K; Yamasaki Y; Ando K
    Rinsho Shinkeigaku; 1977 Aug; 17(8):513-9. PubMed ID: 923169
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
    Tsuboi Y; Uchikado H; Dickson DW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medial temporal regional argyrophilic grain as a possible important factor affecting dementia in Parkinson's disease.
    Homma T; Mochizuki Y; Takahashi K; Komori T
    Neuropathology; 2015 Oct; 35(5):441-51. PubMed ID: 26079638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A 68-year-old woman with dementia and parkinsonism].
    Yokoyama K; Ikebe S; Komatsuzaki Y; Takanashi M; Mori H; Mochizuki H; Mizuno Y
    No To Shinkei; 2002 Feb; 54(2):175-84. PubMed ID: 11889767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dementia in Parkinson's disease].
    Treves TA; Korczyn A
    Harefuah; 1986 May; 110(9):464-6. PubMed ID: 3530918
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD.
    Jellinger KA
    Parkinsonism Relat Disord; 2006 Mar; 12(2):119-20. PubMed ID: 16337163
    [No Abstract]   [Full Text] [Related]  

  • 35. α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
    Quinn JG; Coulson DT; Brockbank S; Beyer N; Ravid R; Hellemans J; Irvine GB; Johnston JA
    Brain Res; 2012 Jun; 1459():71-80. PubMed ID: 22560502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal cord lesions in sporadic Parkinson's disease.
    Del Tredici K; Braak H
    Acta Neuropathol; 2012 Nov; 124(5):643-64. PubMed ID: 22926675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies.
    Johansen KK; White LR; Sando SB; Aasly JO
    Parkinsonism Relat Disord; 2010 Jun; 16(5):307-15. PubMed ID: 20338799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between Parkinson's disease and dementia. A study using proton NMR imaging parameters.
    Besson JA; Mutch WJ; Smith FW; Corrigan FM
    Br J Psychiatry; 1985 Oct; 147():380-2. PubMed ID: 4075025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.
    Svenningsson P; Westman E; Ballard C; Aarsland D
    Lancet Neurol; 2012 Aug; 11(8):697-707. PubMed ID: 22814541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.